An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
More than 230 Bristol Myers Squibb Employees Pedal Across the U.S. to Advance Cancer Research in Seventh Annual Coast 2 Coast 4 Cancer Ride
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Bristol Myers Squibb (NYSE:BMY) employee Mark DeLong is participating in the Coast 2 Coast 4 Cancer cycling event, aiming to raise over $1 million for the V Foundation for Cancer Research. The 3,000-mile ride from Cannon Beach, OR to Long Branch, NJ, which starts today and ends on October 1, involves over 230 riders. Bristol Myers Squibb will match contributions up to $500,000. Since its inception in 2014, the event has raised more than $7.15 million for cancer research.
Positive
Bristol Myers Squibb matches donations made during the event up to $500,000.
The event has raised over $7.15 million for cancer research since 2014.
Participation of over 230 employees reflects strong employee engagement and commitment.
Negative
None.
Riders aspire to raise more than $1 million for the V Foundation for Cancer Research and make a profound difference for patients and families touched by cancer
PRINCETON, N.J.--(BUSINESS WIRE)--
Today, Bristol Myers Squibb (NYSE:BMY) employee Mark DeLong is joining more than 230 of his colleagues in Coast 2 Coast 4 Cancer, an epic ~3,000-mile cycling event on two unique routes (~6,000 miles total) to raise funds for the V Foundation for Cancer Research. Like many of the riders, DeLong has been personally affected by cancer – first when he lost his 16-year-old son Peter to Ewing’s sarcoma, and years later when he was diagnosed with an aggressive form of prostate cancer himself. The ride begins today from Cannon Beach, Ore., and concludes on October 1 in Long Branch, N.J.
Riders will cycle from Cannon Beach, OR to Long Branch, NJ in 24 days (Photo: Bristol Myers Squibb)
“While my son is no longer with us, his spirit and outlook that helped him bravely fight his cancer battle remain with me, and I know every day is an absolute gift,” said DeLong. “I try to give back where I can, for every patient who may need the breakthroughs that come from cancer research.”
Each year, the goal of the Coast 2 Coast 4 Cancer ride is to raise funds for the V Foundation for Cancer Research, a charitable organization dedicated to achieving Victory Over Cancer®, to support groundbreaking research that aims to make a profound difference for patients and their families. The money raised is matched dollar-for-dollar by Bristol Myers Squibb, with a maximum donation of up to $500,000.
“Patients are at the center of everything we do, and as we work to drive progress in cancer research, we know we can’t do it alone,” said Adam Lenkowsky, Senior Vice President, General Manager of U.S. Cardiovascular, Immunology, and Oncology, Bristol Myers Squibb. “The V Foundation has been a longstanding partner of Bristol Myers Squibb and we are proud to catalyze their efforts to fund game-changing research and all-star scientists to accelerate victory over cancer and save lives. Personally, I’m riding for my father-in-law who lost his battle with lung cancer.”
Since the 2020 Coast 2 Coast 4 Cancer ride was postponed due to COVID-19, a record 18 teams are participating in this year’s ride with the 2020 and 2021 teams riding concurrently – one on a northern route and one on a southern route – all meeting at the New Jersey shore. Given the evolving COVID-19 environment, Bristol Myers Squibb has kept riders’ safety a top priority, allowing participants to train virtually and will adhere to COVID-19 guidelines along the ride routes.
The Coast 2 Coast 4 Cancer tradition began in 2014 when a group of oncology employees in the U.S. were compelled to do more for those impacted by cancer. Since then, more than 530 Bristol Myers Squibb employees have volunteered their personal time to fundraise and extensively train for the ride, resulting in more than $7.15 million for cancer research. Some of the riders have been diagnosed with cancer, while others are riding in honor of loved ones affected by the disease.
“People living with cancer faced a year of unprecedented challenges, while the disruptive impact of the COVID-19 pandemic threatened the innovation researchers have worked so hard to advance,” said Shane Jacobson, Chief Executive Officer of the V Foundation for Cancer Research. “Now more than ever, the ongoing fight against cancer depends on groundbreaking research and sustained collective action. We are committed to funding the scientists working at the front lines of cancer research and honored to receive such meaningful support from Bristol Myers Squibb.”
In addition to Coast 2 Coast 4 Cancer in the U.S., the Bristol Myers Squibb global workforce demonstrates its long-standing commitment to cancer research with Country 2 Country 4 Cancer (Europe). After four successful years of the effort abroad, more than 150 Bristol Myers Squibb employees will set out to ride in-country routes in Germany, Switzerland, Italy, France, Spain, Belgium, and the United Kingdom, for nearly 3,000 kilometers total this September. This epic cycling event will raise funds for cancer research and European cancer organizations who are members of the Union for International Cancer Control (UICC).
For more information or to support the riders in the 2021 Coast 2 Coast 4 Cancer ride, please visit cancerbikeride.org or follow the ride on Facebook, Twitter and LinkedIn by using #C2C4C.
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
About the V Foundation for Cancer Research
The V Foundation for Cancer Research was founded in 1993 by ESPN and the late Jim Valvano, legendary North Carolina State University basketball coach and ESPN commentator. The V Foundation has funded more than $260 million in game-changing cancer research grants nationwide through a competitive process strictly supervised by a world-class Scientific Advisory Committee. Because the V Foundation has an endowment to cover administrative expenses, 100% of direct donations is awarded to cancer research and programs. The V team is committed to accelerating Victory Over Cancer®. To learn more, visit v.org.
